Cargando…

Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease

Information on comparative drug efficacy is of great importance for drug development as well as clinical practice. Up to now, the relative efficacy of biologics and small targeted molecules for Crohn’s disease (CD) remains unclear. The objective of this study was to quantify the relative efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Boran, Zhao, Libo, Jin, Siyao, He, Huan, Zhang, Jing, Wang, Xiaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967940/ https://www.ncbi.nlm.nih.gov/pubmed/35371027 http://dx.doi.org/10.3389/fimmu.2022.828219

Ejemplares similares

Model-Based Meta-Analysis in Psoriasis: A Quantitative Comparison of Biologics and Small Targeted Molecules
por: He, Huan, et al.
Publicado: (2021)

Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis
por: Gao, Weiqi, et al.
Publicado: (2023)

In the Wnt of Paneth Cells: Immune-Epithelial Crosstalk in Small Intestinal Crohn’s Disease
por: Armbruster, Nicole S., et al.
Publicado: (2017)

Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
por: Beeraka, Narasimha M., et al.
Publicado: (2020)

Hypersensitivity reactions to small molecule drugs
por: Han, Jiayin, et al.
Publicado: (2022)

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
por: Grobben, Yvonne, et al.
Publicado: (2021)

Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
por: Seok, Jin Kyung, et al.
Publicado: (2021)

pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics
por: Caprio, Vittorio, et al.
Publicado: (2018)

Oral small-molecule tyrosine kinase 2 and phosphodiesterase 4 inhibitors in plaque psoriasis: a network meta-analysis
por: Xu, Yuanyuan, et al.
Publicado: (2023)

Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

Fibrosis in fat: From other diseases to Crohn’s disease
por: Xiong, Shanshan, et al.
Publicado: (2022)

Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials
por: Kang, Qin, et al.
Publicado: (2022)

Innate Lymphoid Cells in Crohn’s Disease
por: Wu, Ying, et al.
Publicado: (2020)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms
por: Chowdhury, Abhinandan, et al.
Publicado: (2021)

Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine
por: Barrio-Calvo, Marina, et al.
Publicado: (2023)

Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders
por: Arnold, Dennis D., et al.
Publicado: (2022)

Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis
por: Guo, Baofeng, et al.
Publicado: (2023)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2023)

Small Molecule Agents Targeting PD-1 Checkpoint Pathway for Cancer Immunotherapy: Mechanisms of Action and Other Considerations for Their Advanced Development
por: Sasikumar, Pottayil G., et al.
Publicado: (2022)

TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and In Silico Search for Small Molecule Binders
por: Shaikh, Faraz, et al.
Publicado: (2018)

The Selective Autophagy Receptor Optineurin in Crohn’s Disease
por: Tschurtschenthaler, Markus, et al.
Publicado: (2018)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Pharmacodynamic Monitoring of RO5459072, a Small Molecule Inhibitor of Cathepsin S
por: Theron, Michel, et al.
Publicado: (2017)

Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
por: Schlicher, Lisa, et al.
Publicado: (2023)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
por: Boyer, Zoe, et al.
Publicado: (2018)

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis
por: Wu, Jing, et al.
Publicado: (2023)

Editorial: Understanding Crohn’s Disease: Immunity, Genes and Microbes
por: Sarmento, Amelia
Publicado: (2017)

What is the future of targeted therapy in rheumatology: biologics or small molecules?
por: Mócsai, Attila, et al.
Publicado: (2014)

Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
por: Romerio, Alessio, et al.
Publicado: (2020)

Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge
por: Saito, Tetsuya, et al.
Publicado: (2021)

Identifying immune cell infiltration and effective diagnostic biomarkers in Crohn’s disease by bioinformatics analysis
por: Huang, Rong, et al.
Publicado: (2023)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
por: Zhang, Cai, et al.
Publicado: (2020)

Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn’s disease
por: Wang, Jing, et al.
Publicado: (2022)

Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
por: Kaegi, Celine, et al.
Publicado: (2022)

Role of immune cell infiltration and small molecule drugs in adhesive capsulitis: Novel exploration based on bioinformatics analyses
por: Liu, Hailong, et al.
Publicado: (2023)

Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis
por: Liu, Wenjie, et al.
Publicado: (2022)

Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn’s disease and ulcerative colitis based on a metalloproteinase-associated module
por: Deng, Jiang, et al.
Publicado: (2022)

Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways
por: Zhou, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3a1u5vkdncj91c74udm8e4t8cg